Finch Reports Results of CP101 in P-II PRISM-EXT Trial for the Prevention of Recurrent C. difficile Infection
November 11, 2021
Immunic Reports Completion of Patient Enrollment in P-II CALDOSE-1 Trial of IMU-838 for the Treatment of Ulcerative Colitis
October 28, 2021
PharmaTher Initiates P-II KET-LID Study of Ketamine for Levodopa-Induced Dyskinesia in Patients with Parkinson's Disease
October 7, 2021
JW Reports One-Year Follow-Up Results of Relmacabtagene Autoleucel in P-II RELIANCE Study for the Treatment of R/R LBCL at CSCO 20...
September 27, 2021
Sorrento Initiates Enrollment in P-II MSC-COV-202BR Study for the Treatment of Acute Respiratory Distress due to COVID-19 in Brazi...
September 7, 2021
AC Immune Report Results of Semorinemab in P-II Lauriet Study for the Treatment of Alzheimer's Disease
September 1, 2021
Back to Home
Incisive News in 3 Shots.
First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
Terms of Service
Copyright © 2024 PharmaShots - All Rights Reserved.